Core Insights - Willis Towers Watson (WTW) has a market capitalization of $30.2 billion and operates in two segments: Health, Wealth & Career, and Risk & Broking, providing integrated services globally [1] Performance Overview - WTW shares have underperformed compared to the broader market over the past 52 weeks, with a marginal increase in stock price while the S&P 500 Index has risen by 11% [2] - Year-to-date, WTW shares are up slightly, contrasting with the S&P 500's gain of 12.3% [2] - The company's stock has also lagged behind the Financial Select Sector SPDR Fund's nearly 3% return over the same period [3] Financial Results - In Q3 2025, WTW reported adjusted EPS of $3.07 and revenue of $2.29 billion, which was better than expected; however, shares fell marginally due to flat year-over-year revenue largely attributed to the sale of the TRANZACT business [4] - The loss of the TRANZACT business, which contributed $1.14 to adjusted EPS in 2024, and the anticipated net headwind of about $0.10 per share from a reinsurance joint venture with Bain Capital were significant factors affecting investor sentiment [4] - Analysts project a slight decline in adjusted EPS to $16.87 for the fiscal year ending December 2025, with a mixed earnings surprise history [5] Analyst Ratings and Price Targets - Among 23 analysts covering WTW, the consensus rating is a "Moderate Buy," with 12 "Strong Buy" ratings, one "Moderate Buy," nine "Holds," and one "Strong Sell" [5] - Barclays analyst Alex Scott has cut the price target on WTW to $303 and reiterated an "Underweight" rating, while the mean price target of $366.63 suggests a 16.4% premium to current price levels [6] - The highest price target of $400 indicates a potential upside of nearly 27% [6]
Willis Towers Watson Stock Outlook: Is Wall Street Bullish or Bearish?